SCHEDULE 13GAccepted Sep 3, 3:05 PM ET
BridgeBio Oncology Therapeutics, Inc. SCHEDULE 13G
Accepted (ET)
3:05 PM
Sep 3, 2025
Filed
Sep 3, 2025
Documents
1
Size
11.5 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.